Cyclopamine, an inhibitor of the transmembrane protein SMO, has shown efficacy against CML stem cells in vitro and in vivo [141], while GANT61, a GLI, inhibitor, blocks GLI function, inhibiting tumor cell growth (Figure 3). Here, GLI1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.